Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
FRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Company will be exhibiting its AC5® Advanced Wound System (“AC5”) at the Symposium on Advanced Wound Care (“SAWC”) Spring 2023, which takes place at National Harbor, MD from April 26-30, 2023.
Related news for (ARTH)
- Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
- Arch Therapeutics Provides Year End Operational Update
- Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
- Arch Therapeutics Provides AC5® Commercialization Update
- Arch Therapeutics Completes Financing as Bridge to Uplisting